IL48116A - Salts of biguanides their manufacture and pharmaceutical compositions containing them - Google Patents

Salts of biguanides their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL48116A
IL48116A IL48116A IL4811675A IL48116A IL 48116 A IL48116 A IL 48116A IL 48116 A IL48116 A IL 48116A IL 4811675 A IL4811675 A IL 4811675A IL 48116 A IL48116 A IL 48116A
Authority
IL
Israel
Prior art keywords
biguanides
salts
manufacture
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL48116A
Other languages
English (en)
Other versions
IL48116A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL48116A0 publication Critical patent/IL48116A0/xx
Publication of IL48116A publication Critical patent/IL48116A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL48116A 1974-10-11 1975-09-17 Salts of biguanides their manufacture and pharmaceutical compositions containing them IL48116A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1369774A CH602612A5 (fr) 1974-10-11 1974-10-11

Publications (2)

Publication Number Publication Date
IL48116A0 IL48116A0 (en) 1975-11-25
IL48116A true IL48116A (en) 1979-07-25

Family

ID=4394567

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48116A IL48116A (en) 1974-10-11 1975-09-17 Salts of biguanides their manufacture and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (1) US4028402A (fr)
JP (1) JPS51125718A (fr)
AR (1) AR209457A1 (fr)
AT (1) AT343676B (fr)
BE (1) BE834369A (fr)
BR (1) BR7506595A (fr)
CA (1) CA1053258A (fr)
CH (1) CH602612A5 (fr)
CU (1) CU34371A (fr)
DD (1) DD123322A5 (fr)
DE (1) DE2542598A1 (fr)
DK (1) DK140834B (fr)
ES (1) ES441673A1 (fr)
FI (1) FI752626A (fr)
FR (1) FR2287221A1 (fr)
GB (1) GB1473256A (fr)
IE (1) IE41807B1 (fr)
IL (1) IL48116A (fr)
LU (1) LU73557A1 (fr)
NL (1) NL7511890A (fr)
NO (1) NO753447L (fr)
PH (1) PH12279A (fr)
PL (1) PL95259B1 (fr)
SE (1) SE7511357L (fr)
SU (1) SU572200A3 (fr)
ZA (1) ZA755861B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401898A1 (fr) * 1977-09-05 1979-03-30 Aec Chim Organ Biolog Nouveau sel de l'acide patoique
DE19616486C5 (de) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust Verfahren zur Senkung des Blutglukosespiegels in Säugern
US20020006899A1 (en) * 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
EP1004304A4 (fr) 1996-12-24 2002-10-16 Sumitomo Pharma Composition contenant de l'acide ascorbique
DE19823831A1 (de) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
DE19940130A1 (de) * 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
WO2001024790A1 (fr) * 1999-10-06 2001-04-12 Kurokawa, Kiyoshi Agents permettant de soulager le stress induit par le carbonyle
US20080076811A1 (en) * 2000-01-21 2008-03-27 Bork Balkan Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
DK2055302T3 (da) * 2000-03-31 2014-10-27 Royalty Pharma Collection Trust Fremgangsmåde til forbedring af signalering af øceller ved diabetes mellitus og til forebyggelse deraf
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2005097117A (ja) * 2000-06-30 2005-04-14 Chugai Pharmaceut Co Ltd 糖尿病治療剤
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
CN1471392A (zh) * 2000-10-27 2004-01-28 ǰ������ҩ��ɷ����޹�˾ 用于治疗神经性及神经心理性疾患的方法
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US20040214762A1 (en) * 2001-08-16 2004-10-28 Hans-Ulrich Demuth Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
KR20040095241A (ko) 2002-02-28 2004-11-12 프로시디온 리미티드 글루타미닐계 ｄｐｉｖ 억제제
US20030232761A1 (en) * 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20040033051A1 (en) * 2002-08-16 2004-02-19 Ip Kiril Kun Wan Method and system for producing and displaying visual presentations which inhibit off-screen duplication
ATE461212T1 (de) * 2002-09-18 2010-04-15 Prosidion Ltd Sekundäre bindungsstelle von dipeptidylpeptidase iv (dp iv)
US20040058876A1 (en) * 2002-09-18 2004-03-25 Torsten Hoffmann Secondary binding site of dipeptidyl peptidase IV (DP IV)
EP1620091B1 (fr) 2003-05-05 2010-03-31 Probiodrug AG Inhibiteurs de glutaminyl-cyclase
PT1620082E (pt) 2003-05-05 2010-06-11 Probiodrug Ag Utilização médica de inibidores de ciclases de glutaminilo e glutamato para o tratamento da doença de alzheimer e síndrome de down
DK1675578T3 (da) * 2003-10-15 2013-08-26 Probiodrug Ag Inhibitorer af glutaminyl- og glutamatcyclaser til behandling af de neurodegenerative sygdomme FBD og FDD
US20100099721A1 (en) * 2003-11-03 2010-04-22 Probiodrug Ag Novel compounds for the treatment of neurological disorders
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
JP4996926B2 (ja) 2004-02-05 2012-08-08 プロビオドルグ エージー グルタミニルシクラーゼの新規の阻害剤
WO2008093984A1 (fr) 2007-01-29 2008-08-07 Hanall Pharmaceutical Company. Ltd Diamide acétate n, n- diméthyl imidodicarbonimidique, son procédé de production et compositions pharmaceutiques le comprenant
WO2008097861A2 (fr) * 2007-02-02 2008-08-14 Braincells, Inc. Modulation d'une neurogénèse avec des biguanides et des agents gsk3-ss
JP5292404B2 (ja) * 2007-09-21 2013-09-18 ハンオル バイオファーマ カンパニー，リミテッド Ｎ，ｎ−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
WO2009088220A2 (fr) * 2008-01-08 2009-07-16 Hanall Pharmaceutical Company. Ltd Diamide nicotinate n,n-diméthyl imidodicarbonimidique, son procédé de production et composition pharmaceutique le comprenant
EP2303838B1 (fr) * 2008-06-26 2013-12-04 Laboratorios Silanes, S.A. de C.V. Nouveau sel de metformine glycinate pour régulation de la glycémie
WO2010146604A2 (fr) 2009-06-18 2010-12-23 Exemed Pharmaceuticals Procédés de préparation de chlorhydrate de metformine
WO2011049400A2 (fr) * 2009-10-23 2011-04-28 한올바이오파마주식회사 Composition pharmaceutique contenant un sel d'addition d'acide de n,n-diméthyl diamide imidocarbonimidique pour une action anticancéreuse
KR101324283B1 (ko) 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
WO2018060962A2 (fr) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Composés d'acides aminés de metformine et leurs procédés d'utilisation
BR112019006401A2 (pt) 2016-09-30 2019-06-25 Laboratorios Silanes S A De C V glicinato de metformina, composições farmacêuticas que compreendem o mesmo e métodos de uso do mesmo
CN106986791A (zh) * 2017-05-11 2017-07-28 杜剑平 一种治疗肿瘤的药物化合物及其制备方法和应用
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives

Also Published As

Publication number Publication date
SE7511357L (sv) 1976-04-12
DE2542598A1 (de) 1976-04-22
DK140834C (fr) 1980-04-28
NL7511890A (nl) 1976-04-13
GB1473256A (en) 1977-05-11
PH12279A (en) 1978-12-12
DK140834B (da) 1979-11-26
NO753447L (fr) 1976-04-13
IL48116A0 (en) 1975-11-25
US4028402A (en) 1977-06-07
CH602612A5 (fr) 1978-07-31
CU34371A (es) 1979-06-01
FI752626A (fr) 1976-04-12
ZA755861B (en) 1976-08-25
SU572200A3 (ru) 1977-09-05
LU73557A1 (fr) 1977-05-24
CA1053258A (fr) 1979-04-24
FR2287221A1 (fr) 1976-05-07
DK457475A (fr) 1976-04-12
PL95259B1 (pl) 1977-10-31
ATA776375A (de) 1977-10-15
AR209457A1 (es) 1977-04-29
BR7506595A (pt) 1976-08-17
AU8497775A (en) 1977-03-24
DD123322A5 (fr) 1976-12-12
AT343676B (de) 1978-06-12
JPS51125718A (en) 1976-11-02
BE834369A (fr) 1976-04-12
IE41807B1 (en) 1980-03-26
ES441673A1 (es) 1977-04-01
IE41807L (en) 1976-04-11

Similar Documents

Publication Publication Date Title
IL48116A (en) Salts of biguanides their manufacture and pharmaceutical compositions containing them
PH16474A (en) Clavulcanic acid,salts and esters thereof and pharmaceutical compositions containing same
IL47860A0 (en) Novel 5,9 beta-disubstituted 2-tetrahydrofuryl-6,7-benzomorphans and their salts,their production and pharmaceutical compositions containing them
IL48704A0 (en) Azolyl-(1)-methanes and their salts,their preparation and pharmaceutical compositions containing them
IL47625A0 (en) Novel quinazoline derivatives and pharmaceutical compositions containing them
IL47877A0 (en) Novel thienothiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL47329A (en) Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL46539A0 (en) Esters of dihydroapovincaminic acid,their preparation and pharmaceutical compositions containing them
IL46893A (en) Pharmaceutical compositions containing 4-oxo- benzopyran-6-etanol or 6-acetic acid derivatives, certain novel compounds of this type and their preparation
IL46965A (en) Pharmaceutical composition containing heparinoidic factor
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
JPS51142094A (en) Iodineecontained product and pharmaceutical composition containing thereof
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
IL47590A (en) Desoxyvincaminic acid and apovincaminic acid amides,their preparation and pharmaceutical compositions containing them
ZA751359B (en) Derivative of gentamine and its salts process of preparation and pharmaceutical compositions
IL47826A (en) 7-aminoalkoxy-chroman and-tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
IL47299A0 (en) Cephalosporin compounds their preparation and pharmaceutical compositions containing them
IL48054A (en) 14-deoxy-14-substituted vincanol derivatives their production and pharmaceutical compositions containing them
IL47892A (en) Cinnamamide derivatives their preparation and pharmaceutical compositions containing them
IL48441A (en) Isoindole derivatives their manufacture and pharmaceutical compositions containing them
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
IL37798A0 (en) Novel fluoro-steroids of thepregnane series and pharmaceutical compositions containing them
IL47969A (en) N-acyl orgoteins, their production and pharmaceutical compositions containing them
IL48527A0 (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,their manufacture and pharmaceutical compositions containing them
IL48219A (en) Quaternary salts of 2 ,17 -dipiper-idino-d-homosteroids,their manufacture and pharmaceutical compositions containing them